Trials / Completed
CompletedNCT07318766
Incentive Spirometer in Liver Transplant Recipients
Effect of Incentive Spirometer on Arterial Blood Gases in Liver Transplant Recipients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluated the effect of adjunctive incentive spirometer on arterial blood gases (ABGs) and early postoperative recovery in liver transplant recipients.
Detailed description
In this prospective , randomized study, 40 adults undergoing living-donor liver transplantation (LT) were assigned to standard post-transplant mobilization and breathing exercises alone (n=20) or standard exercises plus structured IS training (n=20). Arterial blood gases ABG parameters (pH, PO₂, PCO₂, HCO₃-, SpO₂) were measured at baseline and on postoperative days 1-3. Linear mixed-effects models assessed group differences in ABG trajectories; slope analyses quantified decline and recovery phases. Secondary outcomes included intensive care unit (ICU) and hospital length of stay (LOS) and Post-operative pulmonary complications incidence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Incentive Spirometry | An intensive spirometry (IS) is a device that measures inhaled air volume and provides visual feedback as a piston rises during inspiration. It is widely used in respiratory and physical therapy to encourage slow, deep breathing, which helps expand the lungs, open airways, and mimic the natural deep breaths seen in yawning or sighing. |
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2026-01-06
- Last updated
- 2026-01-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07318766. Inclusion in this directory is not an endorsement.